articleThe LancetApr 13, 2023GREEN OA

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

BKBrett KingXZXingqi ZhangWGWalter Gubelin HarchaJCJacek C. SzepietowskiJSJerry Shapiro

Yale University · The First Affiliated Hospital, Sun Yat-sen University · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

251
total citations
FWCI
67.14
Percentile
100%
References
33
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Medicine
  • Alopecia areata
  • Clinical endpoint
  • Placebo
  • Hair loss
  • Internal medicine
  • Adverse effect
  • Scalp
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding